EY to acquire Aqurance.

EY, a global consulting firm specializing in a wide range of services, including strategy, transaction, and audit, focusing on corporate and growth strategies, agreed to acquire Aqurance, a technology consulting company engaged in providing digital transformation, CRM implementation, and regulatory compliance solutions for the life sciences and pharmaceutical industries. Financial terms are not disclosed. "This is a pivotal moment for the industry as life sciences companies make critical decisions about platform migration, compliance and data integration. With the acquisition of Aqurance, the EY organization can offer clients a more integrated pathway — strategy through execution — to unlock the full power of Veeva technology. Together, we will help companies move faster, stay compliant and use data and AI to help drive more informed decisions across the enterprise," Dan Mathews, EY Global Life Sciences Leader.